Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02049541 |
|---|---|
| Brief Title: | Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma |
| First Submitted : | January 28, 2014 |
| First Submitted that Met QC Criteria : | January 29, 2014 |
| First Posted : | January 30, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 27, 2022 |
| Last Update Posted : | June 30, 2022 |